Thermo Fisher Scientific Inc. (LON:0R0H)

London flag London · Delayed Price · Currency is GBP · Price in USD
574.92
+1.40 (0.24%)
At close: Dec 5, 2025
8.35%
Market Cap 161.87B
Revenue (ttm) 32.61B
Net Income (ttm) 4.90B
Shares Out n/a
EPS (ttm) 12.91
PE Ratio 33.04
Forward PE 23.85
Dividend 1.27 (0.22%)
Ex-Dividend Date Sep 15, 2025
Volume 120
Average Volume 1,284
Open 575.73
Previous Close 573.52
Day's Range 570.60 - 578.16
52-Week Range 385.88 - 609.45
Beta 0.91
RSI 49.49
Earnings Date Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1956
Employees 125,000
Stock Exchange London Stock Exchange
Ticker Symbol 0R0H
Full Company Profile

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD Financial Statements

News

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE: TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test. TMO is lagging b...

1 day ago - Benzinga

Thermo Fisher Scientific (TMO) Expands Bioprocessing Presence in Asia

Thermo Fisher Scientific (TMO) Expands Bioprocessing Presence in Asia

2 days ago - GuruFocus

Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitm...

3 days ago - Business Wire

Top 15 High-Growth Dividend Stocks For December 2025

The Top 15 High-Growth Dividend Stocks for December 2025 offer a 1.58% yield and 20.97% five-year dividend growth, appearing 33% undervalued. The watchlist's goal is a 12% long-term CAGR, with Novembe...

3 days ago - Seeking Alpha

Thermo Fisher Scientific (TMO) Announces €2.1 Billion Senior Notes Offering

Thermo Fisher Scientific (TMO) Announces €2.1 Billion Senior Notes Offering

4 days ago - GuruFocus

HSBC Upgrades Thermo Fisher Scientific (TMO) to 'Buy' | TMO Stock News

HSBC Upgrades Thermo Fisher Scientific (TMO) to 'Buy' | TMO Stock News

4 days ago - GuruFocus

Is the Market Bullish or Bearish on Thermo Fisher Scientific Inc?

Thermo Fisher Scientific Inc's (NYSE: TMO) short interest as a percent of float has risen 12.5% since its last report. According to exchange reported data, there are now 4.41 million shares sold shor...

8 days ago - Benzinga

Price Over Earnings Overview: Thermo Fisher Scientific

In the current market session, Thermo Fisher Scientific Inc. (NYSE: TMO) stock price is at $592.02, after a 0.96% drop. However, over the past month, the company's stock went up by 5.32% , and in the...

9 days ago - Benzinga

Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today

Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 15 years by 5.66% on an annualized basis producing an average annual return of 17.76%. Currently, Thermo Fisher Scientif...

10 days ago - Benzinga

Thermo Fisher Scientific (TMO) Prices €2.1 Billion Euro-Denominated Notes

Thermo Fisher Scientific (TMO) Prices €2.1 Billion Euro-Denominated Notes

10 days ago - GuruFocus

Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering

Thermo Fisher Scientific (TMO) announced that it has priced an offering of €2.1 billion in euro-denominated notes, to be issued by its finance subsidiary Thermo Fisher Scientific (Finance I) B.V., tha...

10 days ago - Seeking Alpha

Thermo Fisher Scientific Subsidiary Prices EUR 2.1 Bln Senior Notes Offering

(RTTNews) - Thermo Fisher Scientific Inc. (TMO) has priced an offering of 2.1 billion euros aggregate principal amount of euro-denominated notes, to be issued by Thermo Fisher Scientific (Finance I) B...

11 days ago - Nasdaq

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) ...

11 days ago - Business Wire

Josh Brown's ‘best stocks in the market': Health Care

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's spotlighting Health Care in his "best stocks in the market." The Committee debates their health care s...

11 days ago - CNBC Television

TMO Quantitative Stock Analysis

Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Multi-Factor Investor model based on the published s...

13 days ago - Nasdaq

Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

14 days ago - Nasdaq

Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ ...

15 days ago - Business Wire

TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner

Thermo Fisher's new all-in-one SureTect qPCR assay promises faster, broader beverage spoilage detection and sharper quality control.

15 days ago - Nasdaq

Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing*

WALTHAM, Mass.--(BUSINESS WIRE)--To support the quality of beverage products, Thermo Fisher Scientific today introduced the Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay**, an in...

16 days ago - Business Wire

Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Cente...

17 days ago - Business Wire

Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades'

On CNBC's “ Halftime Report Final Trades ,” Joseph M. Terranova , senior managing director for Virtus Investment Partners, picked Monster Beverage Corporation (NASDAQ: MNST). The beverage company’s s...

17 days ago - Benzinga

Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH

The Investment Committee give you their top stocks to watch for the second half.

18 days ago - CNBC Television

Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH

The Investment Committee give you their top stocks to watch for the second half.

18 days ago - CNBC

Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (M...

18 days ago - Business Wire